 Fibrinolytic Agents
"Fibrinolytic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.
| Descriptor ID |
D005343
|
| MeSH Number(s) |
D27.505.519.421.750 D27.505.954.411.320 D27.505.954.502.427
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrinolytic Agents".
Below are MeSH descriptors whose meaning is more specific than "Fibrinolytic Agents".
This graph shows the total number of publications written about "Fibrinolytic Agents" by people in this website by year, and whether "Fibrinolytic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 1998 | 3 | 2 | 5 | | 1999 | 1 | 0 | 1 | | 2000 | 2 | 0 | 2 | | 2001 | 1 | 2 | 3 | | 2002 | 2 | 0 | 2 | | 2003 | 2 | 0 | 2 | | 2005 | 1 | 4 | 5 | | 2006 | 5 | 3 | 8 | | 2007 | 2 | 1 | 3 | | 2008 | 0 | 2 | 2 | | 2009 | 6 | 4 | 10 | | 2010 | 4 | 0 | 4 | | 2011 | 5 | 5 | 10 | | 2012 | 6 | 3 | 9 | | 2013 | 5 | 3 | 8 | | 2014 | 7 | 7 | 14 | | 2015 | 4 | 3 | 7 | | 2016 | 8 | 2 | 10 | | 2017 | 9 | 2 | 11 | | 2018 | 7 | 5 | 12 | | 2019 | 3 | 1 | 4 | | 2020 | 13 | 3 | 16 | | 2021 | 3 | 8 | 11 | | 2022 | 3 | 9 | 12 | | 2023 | 1 | 8 | 9 | | 2024 | 5 | 6 | 11 | | 2025 | 9 | 2 | 11 | | 2026 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Fibrinolytic Agents" by people in Profiles.
-
Aboul-Nour H, Siegler JE, Thompson SL, Glover PA, Daniel JA, Penckofer M, Smith MM, Yaghi S, Ro J, Chen L, D'Souza M, Khasiyev F, Kerrigan D, Sharma R, Aziz YN, Kirchhoffer K, Kam W, Melkumova E, Sloane KL, Lineback CM, Thottempudi N, Heaton S, Linares G, Singh E, Almallouhi E, Stretz C, Albert Fernandez CJ, Dumitrascu OM, Culbertson CJ, Elangovan C, Bowman A, Valhuerdi Porto C, Chahien D, Herpich F, Farooqui M, Kang J, de Havenon A, Nelson A, Shahrivari M, Stamm B, Khezri N, Lewis S, Sathya A, Leung LY, Eklund K, Rojas-Soto D, Nedelcu S, Al Kasab S, Van Coevering RJ, Thon J, Jillella DV, Nahab FB. Real-World Practice in Secondary Stroke Prevention Following Embolic Stroke of Undetermined Source: Secondary Analysis of the CASPR Registry. Neurol Clin Pract. 2026 Aug; 16(4):e200631.
-
Singh N, Strbian D, Vatanpour S, Field TS, Yu AYX, Ganesh A, Barber PA, Choi PMC, Buck BH, Kleinig TJ, Campbell B, Molina C, Muir KW, Hill MD, Coutts SB. Association of Successful Recanalization and Functional Outcomes in Minor Ischemic Stroke With Proven Occlusion: A Secondary Analysis of TEMPO-2 Trial. Stroke. 2026 Aug; 57(8):2305-2314.
-
Massicotte S, Vatanpour S, Doolan C, Zhang J, Ganesh A, Choi PMC, Buck BH, Field TS, Yu AYX, Kleinig TJ, Muir KW, Campbell BCV, Molina CA, Appireddy R, Hill MD, Singh N, Coutts SB. Intracranial Hemorrhage Patterns and Outcomes in Minor Stroke: Analysis of the TEMPO-2 Trial. Stroke. 2026 Jun; 57(6):1526-1534.
-
Navi BB, Wang M, Yamal JM, Rajan SS, Czap AL, Parker SA, Nour M, Spokoyny I, Mir S, Fink ME, Willey JZ, Jones WJ, Grotta JC. Potential Missed Opportunities to Administer Intravenous Thrombolysis to Patients With Acute Ischemic Stroke. Stroke. 2026 Mar; 57(3):633-640.
-
Zhang Y, Buck BH, Barber PA, Chatterjee K, Clarke B, Choi PMC, Hunter G, Ganesh A, Mishra SM, Williams D, Campbell BCV, Dowlatshahi D, Butcher KS, Krishnan K, Wiggam MI, Kleinig TJ, Muir KW, Zerna C, Field TS, Goyal M, Yu AYX, Roffe C, Demchuck AM, Parsons MW, Bazan R, Ankolekar S, Kennedy J, Menon BK, Mandzia JL, Pille A, Kelly PJ, Marko M, Singh N, Vatanpour S, Lima FO, Catanese L, Horn M, Ghia D, Ferrari J, Greisenegger S, Hill MD, Coutts SB. Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical Trial. JAMA Neurol. 2025 12 01; 82(12):1243-1250.
-
Gonsalves CF, Stortecky S, Horr S, Pappas O, Gandhi RT, Pereira K, Giri J, Khandhar SJ, Azene EM, Elmasri F, Lindquist J, Jaber WA. Evaluation of Catheter-Directed Thrombolysis Device Type and Dosing on Treatment Outcomes in Intermediate-Risk Pulmonary Embolism: A PEERLESS Randomized Controlled Trial Post Hoc Analysis. J Vasc Interv Radiol. 2026 01; 37(1):107866.
-
Chaudhry-Waterman N, Schardt TQ, Soderstrom RM, Warren BB, Buckvold S, Morgan G, Kim JS. Catheter-Directed Bivalirudin for Local Anticoagulation and Clot Dissolution in Children Requiring Mechanical Circulatory Support. ASAIO J. 2026 02 01; 72(2):e24-e28.
-
Moore PK, Hershberger DM, Barrett CD. Intrapleural Fibrinolytic Therapy: Past, Present, and Future. Chest. 2026 Feb; 169(2):360-370.
-
Verheye S, Ferdinande B, Bennett J, Staico R, El-Jack S, Tonino PAL, Abizaid A, Buysschaert I, Scott D, Menon M, Wilkins G, McClean D, Kovarnik T, Christians U, Neylon A, Mehmedbegovic Z, Smits PC, Morice MC, Webster M. Site-Specific Antithrombotic Therapy: 24-Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple-Drug Eluting Coronary Implant With Two Anticoagulants and Sirolimus. Catheter Cardiovasc Interv. 2025 Oct; 106(4):2770-2780.
-
Maginot ER, Gawargi FI, Moore EE, White CM, Volk GE, Moody TB, Sextro KS, Hiser D, Tierney JF, Sheppard OO, Evans CH, Cantrell E, Kamien AJ, Lamb GD, Matos M, Veatch J, Cloonan MR, Chandler JG, Moore HB, Moore PK, Sauaia A, Bernhardt IM, Yaffe MB, Bauman ZM, Henry R, Barrett CD. Plasminogen supplementation improves lysis of inflammatory retained traumatic hemothorax. J Trauma Acute Care Surg. 2026 01 01; 100(1):20-27.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|